Shanghai Hongene Biotech Corporation.: Biomedicine Brief

Summary

Shanghai Hongene Biotech Corporation. is indexed in the China Little Giant company database. The profile is associated with Shanghai. The report is grouped under Biomedicine. Recognition context: 2023 5th batch. Chinese source report date: 2026-06-12. 6 source-page links are available on this page or in the Chinese report. The English brief covers company profile, product direction, industry-chain role, patent and R&D signals, scale indicators and policy-material checkpoints, with internal links to the company page, Chinese source report and related topic hubs.

English Data Summary

This is a structured summary of the portal's recorded company fields, not a full English translation of the Chinese report or an independently verified company thesis.

Recorded Company Profile

• Company: Shanghai Hongene Biotech Corporation.
• Region: Shanghai
• Recorded industry: Biomedicine
• Recorded chain position: Biomedicine and medical devices / Complete systems and application scenarios
• Recorded recognition context: 2023 5th batch
• Registered-capital field: RMB 1,728.38 million
• Employee field: 707 employees
• Listing-status field: Not listed
• Patent-related record count: 90

Industry-chain Context

Industry and chain-position labels describe the portal's database classification. They do not establish a specific production process, client list, competitive advantage or a company's participation in an adjacent sector.

Research Boundary and Original Report

Registration, employee and patent fields retain their recorded database scope; their presence does not establish current capacity, financial performance or ownership of any specific patent. Company-specific products, financial figures, customers and operating claims require the original disclosures. Chinese page provides the corresponding profile and source links. This summary does not constitute investment advice or confirmation of a policy application outcome.